Juul Labs is asking a judge to order the US Food and Drug Administration (FDA) to release information related to its now-vacated denial of the company’s premarket tobacco application (PMTA), calling the withholding of material “part of a troubling pattern of decreasing transparency at the agency”.
In a lawsuit filed 20th September, lawyers for Juul said they served the FDA with two requests for the “scientific disciplinary reviews” behind its decision to reject the PMTA and order all Juul products off the US market. The requests were made “less than a day” after the FDA issued its marketing denial order (MDO) to Juul on 23rd June.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
